(Reuters) - Drugmaker Pfizer Inc (>> Pfizer Inc.) is thinking about selling hospital products maker Hospira's infusion pump business for about $2 billion, Bloomberg reported, citing people familiar with the matter.

Talks are said to be at an early stage, Bloomberg reported on Wednesday. (http://bloom.bg/1OQhp8A)

Pfizer closed its $15 billion acquisition of Hospira, which makes biosimilars and generic versions of injectable drugs, in September.

A Pfizer spokeswoman declined to comment.

Infusion pumps are computerized and are designed to deliver medications directly into patients' bloodstreams.

In November, Pfizer said it would buy Botox maker Allergan Plc (>> Allergan, Inc.) in a deal worth $160 billion, which would create the world's largest drugmaker.

(Reporting by Anya George Tharakan in Bengaluru; Editing by Sunil Nair)

Stocks treated in this article : Allergan, Inc., Allergan plc, Pfizer Inc.